Friday - August 15, 2025
Paul Hastings Advised Global Coordinators, Bookrunners in Connection With GenSight Biologics' PIPE Financing
May 11, 2024
LOS ANGELES, California, May 11 -- Paul Hastings, a law firm, issued the following news:

Paul Hastings LLP advised Chardan Capital Markets and Invest Securities as joint global coordinators and bookrunners in connection with GenSight Biologics' private placement (PIPE).

GenSight Biologics (Euronext: SIGHT) is a French biopharma company focused on developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders.
. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products